Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. NJPS [Internet]. 31 Tháng Chạp 2025 [cited 31 Tháng Năm 2026];40(2):251-62. Available at: http://www.ojshostng.com/index.php/njphysiologicalsciences/article/view/4001